当前位置：药药网 / 药品研发 / 美国药品上市后承诺数据库
AFLURIA; Afluria Quadrivalent, Influenza Vaccine
药品名称
AFLURIA; Afluria Quadrivalent, Influenza Vaccine
承诺描述
To establish a pregnancy registry to prospectively collect data on reported exposures to Afluria Quadrivalent during pregnancy and evaluate pregnancy outcomes. The registry will enroll a minimum of 500 evaluable subjects
报告接收日期
2020/10/21 0:00:00